Guimin Xia

5PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersGlycoconjugatesNanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 19, 2025
Mitophagy and Bip-PERK-eIF2α-ATF4 Axis-Mediated ER Stress Mediate Miriplatin-Loaded Liposome's Anti-Colorectal Cancer Action.

Cong Zhao, Yuhan Qiu, Xiaowei Wang

|Jan 31, 2025
Phosphoproteomics delineates hepatocellular carcinoma subtypes and pinpoints therapeutic targets.

Ze Zhang, Zhenpeng Zhang, Yao Zhang

|Oct 04, 2024
A Dual-Function LipoAraN-E5 Coloaded with N4-Myristyloxycarbonyl-1-β-d-arabinofuranosylcytosine (AraN) and a CXCR4 Antagonistic Peptide (E5) for Blocking the Dissemination of Acute Myeloid Leukemia.

Xuelei Wang, Xiaowei Wang, Jiayi Su

|Jan 04, 2024
Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections.

Xiaobo Wang, Dan Wang, Hongwei Lu

|Jun 22, 2022
Novel 5-Fluorouracil Carbonate-Loaded Liposome: Preparation, In Vitro, and In Vivo Evaluation as an Antitumor Agent.

Xuelei Wang, Apeng Wang, Wenkai Feng

Pageof 1

Frequent Collaborators

2 joint publications

Mingliang Liu

1 joint publications

Xiaobo Wang

1 joint publications

Ze Zhang

1 joint publications

Zhenpeng Zhang